| 1 |
Eli Lilly & Co |
LLY |
Pharmaceutical Preparations |
$825.7B |
ETF-tracked |
| 2 |
Johnson & Johnson |
JNJ |
Pharmaceutical Preparations |
$572.7B |
ETF-tracked |
| 3 |
AbbVie Inc |
ABBV |
Pharmaceutical Preparations |
$375.1B |
ETF-tracked |
| 4 |
Merck & Co Inc |
MRK |
Pharmaceutical Preparations |
$283.0B |
ETF-tracked |
| 5 |
Abbott Laboratories |
ABT |
Pharmaceutical Preparations |
$189.1B |
ETF-tracked |
| 6 |
Pfizer Inc |
PFE |
Pharmaceutical Preparations |
$155.5B |
ETF-tracked |
| 7 |
Vertex Pharmaceuticals Inc |
VRTX |
Pharmaceutical Preparations |
$115.8B |
ETF-tracked |
| 8 |
Regeneron Pharmaceuticals Inc |
REGN |
Pharmaceutical Preparations |
$79.3B |
ETF-tracked |
| 9 |
Alnylam Pharmaceuticals Inc |
ALNY |
Pharmaceutical Preparations |
$42.1B |
ETF-tracked |
| 10 |
BioMarin Pharmaceutical Inc |
BMRN |
Pharmaceutical Preparations |
$10.6B |
ETF-tracked |
| 11 |
Corcept Therapeutics Inc |
CORT |
Pharmaceutical Preparations |
$3.6B |
ETF-tracked |
| 12 |
Apellis Pharmaceuticals Inc |
APLS |
Pharmaceutical Preparations |
$2.3B |
ETF-tracked |